This is a good announcement and should not be underestimated in the necessity to have the back end systems support a great product. data integration and ease of access and reporting is what is required for all these new health products to enter mainstream. Same issues at PCK though they recognised earlier that back end systems were key. So this is a good move as Rimidi are across 17 states.
Ann: Rimidi Partnership for Respiratory Clinical Management, page-2
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $12.41M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.7¢ | 1.6¢ | $946 | 55.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 101 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 703695 | 4 |
View Market Depth
| Last trade - 13.57pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.6¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 1.6¢ | 1.7¢ | 1.6¢ | 269283 | ||
| Last updated 14.58pm 17/06/2024 ? | |||||
| ADR (ASX) Chart |
